Capital International Investors Decreased Analog Devices (ADI) Holding By $66.09 Million; Anika Therapeutics (ANIK)’s Sentiment Is 1.37

April 22, 2018 - By Nellie Frank

Analog Devices, Inc. (NASDAQ:ADI) Logo

Capital International Investors decreased Analog Devices Inc (ADI) stake by 19.87% reported in 2017Q4 SEC filing. Capital International Investors sold 742,618 shares as Analog Devices Inc (ADI)’s stock rose 2.48%. The Capital International Investors holds 2.99 million shares with $266.57 million value, down from 3.74 million last quarter. Analog Devices Inc now has $33.19B valuation. The stock decreased 0.10% or $0.09 during the last trading session, reaching $89.76. About 4.01M shares traded or 31.16% up from the average. Analog Devices, Inc. (NASDAQ:ADI) has risen 11.86% since April 22, 2017 and is uptrending. It has outperformed by 0.31% the S&P500.

Anika Therapeutics Inc (ANIK) investors sentiment decreased to 1.37 in 2017 Q4. It’s down -0.05, from 1.42 in 2017Q3. The ratio dived, as 78 funds increased and started new equity positions, while 57 sold and trimmed stock positions in Anika Therapeutics Inc. The funds in our database now have: 12.26 million shares, down from 12.29 million shares in 2017Q3. Also, the number of funds holding Anika Therapeutics Inc in top ten equity positions was flat from 2 to 2 for the same number . Sold All: 12 Reduced: 45 Increased: 54 New Position: 24.

Healthinvest Partners Ab holds 13.04% of its portfolio in Anika Therapeutics, Inc. for 114,600 shares. Thomson Horstmann & Bryant Inc owns 243,090 shares or 1.73% of their US portfolio. Moreover, Ami Asset Management Corp has 1.03% invested in the company for 276,041 shares. The Virginia-based Capital Management Corp Va has invested 0.89% in the stock. Kayne Anderson Rudnick Investment Management Llc, a California-based fund reported 1.67 million shares.

The stock decreased 0.88% or $0.4 during the last trading session, reaching $45.13. About 84,457 shares traded. Anika Therapeutics, Inc. (ANIK) has risen 15.35% since April 22, 2017 and is uptrending. It has outperformed by 3.80% the S&P500.

Anika Therapeutics, Inc., together with its subsidiaries, provides orthopedic medicines for patients with degenerative orthopedic diseases and traumatic conditions in the United States and internationally. The company has market cap of $665.45 million. The firm develops, makes, and commercializes therapeutic products based on its proprietary hyaluronic acid technology. It has a 21.39 P/E ratio. The Company’s orthobiologics products comprise ORTHOVISC, ORTHOVISC mini, MONOVISC, and CINGAL for the treatment of osteoarthritis of the knee; HYALOFAST, a biodegradable support for human bone marrow mesenchymal stem cells used for cartilage regeneration and as an adjunct for microfracture surgery; HYALONECT, a woven gauze used as a bone graft wrap; HYALOSS used to mix blood/bone grafts to form a paste for bone regeneration; and HYALOGLIDE, an ACP gel used in tenolysis treatment.

Analysts await Anika Therapeutics, Inc. (NASDAQ:ANIK) to report earnings on May, 2. They expect $0.25 earnings per share, down 32.43% or $0.12 from last year’s $0.37 per share. ANIK’s profit will be $3.69M for 45.13 P/E if the $0.25 EPS becomes a reality. After $0.38 actual earnings per share reported by Anika Therapeutics, Inc. for the previous quarter, Wall Street now forecasts -34.21% negative EPS growth.

Since October 23, 2017, it had 0 insider purchases, and 17 selling transactions for $11.75 million activity. Another trade for 7,000 shares valued at $640,640 was made by SEIF MARGARET K on Friday, January 5. $402,882 worth of Analog Devices, Inc. (NASDAQ:ADI) was sold by Real Peter. $65,259 worth of Analog Devices, Inc. (NASDAQ:ADI) shares were sold by Jamal Yusuf. STATA RAY sold $911,300 worth of Analog Devices, Inc. (NASDAQ:ADI) on Wednesday, January 3. ROCHE VINCENT sold $904,700 worth of Analog Devices, Inc. (NASDAQ:ADI) on Monday, April 2. 4,000 shares were sold by Henderson Gregory N., worth $366,080 on Friday, January 5. $226,292 worth of Analog Devices, Inc. (NASDAQ:ADI) was sold by CHAMPY JAMES on Thursday, March 22.

Capital International Investors increased Medtronic Plc (NYSE:MDT) stake by 7,873 shares to 4.43 million valued at $357.32 million in 2017Q4. It also upped On Semiconductor Corp (ONNN) stake by 101,528 shares and now owns 24.16M shares. Las Vegas Sands Corp (NYSE:LVS) was raised too.

Among 33 analysts covering Analog Devices (NASDAQ:ADI), 23 have Buy rating, 0 Sell and 10 Hold. Therefore 70% are positive. Analog Devices had 130 analyst reports since July 22, 2015 according to SRatingsIntel. As per Monday, October 2, the company rating was maintained by RBC Capital Markets. RBC Capital Markets maintained it with “Buy” rating and $9000 target in Tuesday, May 30 report. Wells Fargo downgraded the stock to “Market Perform” rating in Thursday, February 16 report. The rating was reinitiated by RBC Capital Markets on Monday, August 3 with “Outperform”. The firm earned “Buy” rating on Thursday, October 19 by Jefferies. Susquehanna initiated Analog Devices, Inc. (NASDAQ:ADI) rating on Thursday, August 6. Susquehanna has “Neutral” rating and $65 target. The rating was maintained by Oppenheimer with “Buy” on Wednesday, August 30. The stock of Analog Devices, Inc. (NASDAQ:ADI) earned “Buy” rating by Oppenheimer on Thursday, February 22. Oppenheimer maintained the shares of ADI in report on Friday, November 17 with “Buy” rating. The stock has “Buy” rating by BMO Capital Markets on Friday, October 20.

Analog Devices, Inc. (NASDAQ:ADI) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>